{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:50:45Z","timestamp":1792601445828,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","award":["2023094"],"award-info":[{"award-number":["2023094"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","award":["2019067"],"award-info":[{"award-number":["2019067"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","award":["2024016"],"award-info":[{"award-number":["2024016"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.atherosclerosis.2026.120642","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T07:26:11Z","timestamp":1768634771000},"page":"120642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Circulating B-cell activating factor in acute coronary syndromes \u2013 association with adverse outcomes and progression of heart failure"],"prefix":"10.1016","volume":"414","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5005-0784","authenticated-orcid":false,"given":"Thor","family":"Ueland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir \u00d8ystein","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharanga","family":"Varathalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sverre","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanmuganathan","family":"Limalanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika Elisabeth","family":"Michelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaspar","family":"Broch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l","family":"Aukrust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Gullestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente","family":"Halvorsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.atherosclerosis.2026.120642_bib1","article-title":"Inflammation during the life cycle of the atherosclerotic plaque","volume":"117","author":"Libby","year":"2021","journal-title":"Cardiovasc Res"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120642_bib2","article-title":"Aging, and cardiovascular disease: JACC review topic of the week","volume":"79","author":"Liberale","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120642_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-018-0106-9","article-title":"The role of B cells in atherosclerosis","volume":"16","author":"Sage","year":"2019","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120642_bib4","article-title":"Cells in atherosclerosis: mechanisms and potential clinical applications","volume":"6","author":"Pattarabanjird","year":"2021","journal-title":"JACC Basic Transl Sci"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2026.120642_bib5","article-title":"Humoral immunity in atherosclerosis and myocardial infarction: from B cells to antibodies","volume":"117","author":"Porsch","year":"2021","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120642_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020270","article-title":"Functional role of B cells in atherosclerosis","volume":"10","author":"Ma","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120642_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-065X.2011.01067.x","article-title":"Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease","volume":"244","author":"Rickert","year":"2011","journal-title":"Immunol Rev"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120642_bib8","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/nm.3284","article-title":"\/B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction","volume":"19","author":"Zouggari","year":"2013","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120642_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/nri844","article-title":"BAFF: a fundamental survival factor for B cells","volume":"2","author":"Mackay","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.atherosclerosis.2026.120642_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02285","article-title":"BAFF and BAFF-receptor in B cell selection and survival","author":"Smulski","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.atherosclerosis.2026.120642_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1050528","article-title":"Clark EA\/B cell-activating factor (BAFF) from dendritic cells, monocytes and neutrophils is required for B cell maturation and autoantibody production in SLE-Like autoimmune disease","author":"Giordano","year":"2023","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120642_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.111.244731","article-title":"BAFF receptor deficiency reduces the development of atherosclerosis in mice--brief report","volume":"32","author":"Sage","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120642_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060430","article-title":"BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE(-\/-) mice","volume":"8","author":"Kyaw","year":"2013","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2026.120642_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.117.032790","article-title":"Binder CJ\/B cell-activating factor neutralization aggravates atherosclerosis","volume":"138","author":"Tsiantoulas","year":"2018","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120642_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.119.311996","article-title":"Impact of B-Cell-Targeted therapies on cardiovascular disease","volume":"39","author":"Porsch","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120642_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12041692","article-title":"\/association of serum BAFF levels with cardiovascular events in ST-Segment elevation myocardial infarction","volume":"12","author":"Wang","year":"2023","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120642_bib17","doi-asserted-by":"crossref","DOI":"10.1159\/000316965","article-title":"Rationale and design of the POSTEMI (postconditioning in ST-elevation myocardial infarction) study","volume":"116","author":"Limalanathan","year":"2010","journal-title":"Cardiology"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120642_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000679","article-title":"Effect of ischemic postconditioning on infarct size in patients with ST-elevation myocardial infarction treated by primary PCI results of the POSTEMI (POstconditioning in ST-Elevation myocardial infarction) randomized trial","volume":"3","author":"Limalanathan","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120642_bib19","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.135.5.3172","article-title":"Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro","volume":"135","author":"Rubin","year":"1985","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120642_bib20","doi-asserted-by":"crossref","DOI":"10.1097\/QAD.0000000000000735","article-title":"Soluble CD14 is a nonspecific marker of monocyte activation","volume":"29","author":"Shive","year":"2015","journal-title":"Aids"},{"key":"10.1016\/j.atherosclerosis.2026.120642_bib21","first-page":"64047","article-title":"Myeloperoxidase: its role for host defense, inflammation, and neutrophil function","author":"Aratani","year":"2018","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120642_bib22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1186\/s12872-024-04146-w","article-title":"Serum BAFF level is associated with the presence and severity of coronary artery disease and acute myocardial infarction","volume":"24","author":"Chen","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120642_bib23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12872-020-01775-9","article-title":"Are activated B cells involved in the process of myocardial fibrosis after acute myocardial infarction? An in vivo experiment","volume":"21","author":"Mo","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120642_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.124.319845","article-title":"\/T-Cell\/B-Cell interactions in Atherosclerosis\/arterioscler","volume":"44","author":"Jones","year":"2024","journal-title":"Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120642_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/14728222.2020.1708325","article-title":"Bobik A\/evolving BAFF targeted therapies for preventing acute myocardial infarctions and ischemic strokes","volume":"24","author":"Kyaw","year":"2020","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.atherosclerosis.2026.120642_bib26","article-title":"The role of major immune cells in myocardial infarction","author":"Feng","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120642_bib27","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.167201","article-title":"Cell subsets contribute to myocardial protection by inducing neutrophil apoptosis after ischemia and reperfusion","volume":"9","author":"Huang","year":"2024","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120642_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4049\/jimmunol.2200410","article-title":"Cutting edge: neutrophil complement receptor signaling is required for BAFF-Dependent humoral responses in mice","volume":"210","author":"Cumpelik","year":"2023","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2026.120642_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.636954","article-title":"Neutrophil extracellular traps activate proinflammatory functions of human neutrophils","author":"D\u00f6mer","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120642_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-3083.2007.02049.x","article-title":"Mariette X\/B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sj\u00f6gren's syndrome","volume":"67","author":"Lavie","year":"2008","journal-title":"Scand J Immunol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120642_bib31","article-title":"\/therapeutic avenues to modulate B-Cell function in patients with cardiovascular disease","volume":"44","author":"O'Brien","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120642_bib32","article-title":"BAFF is a marker of hypogammaglobulinemia, neuroaxonal damage and inflammation in multiple sclerosis patients on ocrelizumab","volume":"23","author":"Chumakova","year":"2025","journal-title":"J Neuroinflammation"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120642_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/art.38074","article-title":"Elevated serum BAFF levels are associated with rising anti-double-stranded DNA antibody levels and disease flare following B cell depletion therapy in systemic lupus erythematosus","volume":"65","author":"Carter","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120642_bib34","first-page":"85","article-title":"The involvement of immune reactions in cardiac damage during acute myocardial infarction: role of cell-mediated immune response","volume":"39","author":"Dimitrijevic","year":"1997","journal-title":"Panminerva Med"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120642_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.14619","article-title":"Sluijter JPG\/Increased circulating IgG levels, myocardial immune cells and IgG deposits support a role for an immune response in pre- and end-stage heart failure","volume":"23","author":"van den Hoogen","year":"2019","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120642_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-237549","article-title":"Clinical improvement of cardiac function in a patient with systemic lupus erythematosus and heart failure with preserved ejection fraction treated with belimumab","volume":"14","author":"Baniaamam","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120642_bib37","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-024-06904-9","article-title":"Impact of subcutaneous belimumab on disease activity, patient satisfaction, and metabolic profile in long-lasting systemic lupus erythematosus","volume":"43","author":"Yamato","year":"2024","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120642_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keae192","article-title":"Improvement of high-density lipoprotein atheroprotective properties in patients with systemic lupus erythematosus after belimumab treatment","volume":"64","author":"Dedemadi","year":"2025","journal-title":"Rheumatology"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026000080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026000080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T17:57:33Z","timestamp":1773856653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915026000080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":38,"alternative-id":["S0021915026000080"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120642","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating B-cell activating factor in acute coronary syndromes \u2013 association with adverse outcomes and progression of heart failure","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120642","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120642"}}